| 2026-08-13 | Press release | OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdut |
| 2026-07-27 | Press release | OPKO Health Reports Second Quarter 2026 Business Highlights and Financial Results |
| 2026-07-23 | Press release | OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026 |
| 2026-06-15 | Press release | Preclinical Data for OPKO Biologics' OPK8801001 in Acromegaly Presented at ENDO 2026 |
| 2026-05-12 | Press release | OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion |
| 2026-05-08 | Presentation | Corporate Presentation |
| 2026-04-30 | Press release | OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China |
| 2026-04-30 | Press release | BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully I |
| 2026-04-28 | Press release | OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results |
| 2026-04-28 | Press release | PDF |
| 2026-04-22 | Press release | OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas |
| 2026-04-21 | Press release | OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026 |
| 2026-04-08 | Press release | OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19 |
| Press release | OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results |
| Press release | OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26 |
| Press release | OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results |
| Press release | OPKO Health to Report Third Quarter 2025 Financial Results on October 29 |
| Press release | OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results |
| Press release | OPKO Health to Report Second Quarter 2025 Financial Results on July 31 |
| 2025-07-08 | Press release | OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Sel |
| Press release | OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results |
| 2025-02-27 | Press release | OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results |
| 2025-02-13 | Press release | OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025 |
| 2024-11-07 | Press release | OPKO Health Reports Third Quarter 2024 Business Highlights and Financial Results |
| 2024-10-29 | Press release | OPKO Health to Report Third Quarter 2024 Financial Results on November 7, 2024 |
| 2024-08-07 | Press release | OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results |
| 2024-08-01 | Press release | OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024 |
| 2024-05-07 | Press release | OPKO Health Reports First Quarter 2024 Business Highlights and Financial Results |
| 2024-05-03 | Press release | OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024 |
| 2024-02-27 | Press release | OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results |
| 2024-02-22 | Press release | OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024 |
| 2024-01-09 | Press release | OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exerc |
| 2024-01-04 | Press release | OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029 |
| 2024-01-03 | Press release | OPKO Health Announces Private Offering of Convertible Senior Notes Due 2029 |
| 2023-11-06 | Press release | OPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results |
| 2023-11-02 | Press release | New Clinical Data on OPKO Health’s RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023 |
| 2023-10-31 | Press release | OPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023 |
| 2023-10-25 | Press release | OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023 |
| 2023-08-03 | Press release | OPKO Health Reports Second Quarter 2023 Business Highlights and Financial Results |
| 2023-07-25 | Press release | OPKO Health to Report Second Quarter 2023 Financial Results on August 3, 2023 |